QQ客服 官方微博 反馈留言

	Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors
	Wei Huiqiang; Duan Yuqing; Gou Wenfeng; Cui Jie; Ning Hongxin; Li Deguan; Qin Yong; Liu Qiang; Li Yiliang
	2019
卷号	181页码:111552
关键词	3-Nitro-1 2 4-triazole EGFR Hypoxia Tyrosine kinase inhibitor VEGFR-2 Vandetanib
ISSN号	1768-3254
DOI	10.1016/j.ejmech.2019.07.055
URL标识	查看原文
收录类别	PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6337959
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Wei Huiqiang,Duan Yuqing,Gou Wenfeng,et al. Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors[J],2019,181:111552.
APA	Wei Huiqiang.,Duan Yuqing.,Gou Wenfeng.,Cui Jie.,Ning Hongxin.,...&Li Yiliang.(2019).Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors.,181,111552.
MLA	Wei Huiqiang,et al."Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors".181(2019):111552.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。